Targeting of hematopoietic progenitor cells with MR contrast agents. - Wikidata - awgldk - TriplyDB

Targeting of hematopoietic progenitor cells with MR contrast agents.

Targeting of hematopoietic progenitor cells with MR contrast agents.

http://www.wikidata.org/entity/Q44526114

about

Molecular magnetic resonance imaging of brain-immune interactions Nanoplatforms for constructing new approaches to cancer treatment, imaging, and drug delivery: what should be the policy?Iron labeling and pre-clinical MRI visualization of therapeutic human neural stem cells in a murine glioma model Synthesis of Cationized Magnetoferritin for Ultra-fast Magnetization of Cells Quantitative T2* imaging of metastatic human breast cancer to brain in the nude rat at 3 T Clinical applications of iron oxide nanoparticles for magnetic resonance imaging of brain tumors.Mechanism of cellular uptake and impact of ferucarbotran on macrophage physiology.Superparamagnetic iron oxide nanoparticles: diagnostic magnetic resonance imaging and potential therapeutic applications in neurooncology and central nervous system inflammatory pathologies, a review Study on ASTC-a-1 cells labeled with superparamagnetic iron oxide and its magnetic resonance imaging.Dose-response of superparamagnetic iron oxide labeling on mesenchymal stem cells chondrogenic differentiation: a multi-scale in vitro study.Imaging approaches for the study of cell-based cardiac therapies Fluorophore-conjugated iron oxide nanoparticle labeling and analysis of engrafting human hematopoietic stem cells.MR Imaging of Stem Cell Transplants in Arthritic Joints.Cationic Gd-DTPA liposomes for highly efficient labeling of mesenchymal stem cells and cell tracking with MRI.The influence of ferucarbotran on the chondrogenesis of human mesenchymal stem cells.Tracking of mesenchymal stem cells labeled with gadolinium diethylenetriamine pentaacetic acid by 7T magnetic resonance imaging in a model of cerebral ischemia.In vivo magnetic resonance imaging and optical imaging comparison of viable and nonviable mesenchymal stem cells with a bifunctional label R2* and R2 mapping for quantifying recruitment of superparamagnetic iron oxide-tagged endothelial progenitor cells to injured liver: tracking in vitro and in vivo.In vivo monitoring of cellular transplants by magnetic resonance imaging and positron emission tomography.Molecular imaging in vivo: an introduction.Labeling Human Melanoma Cells With SPIO: In Vitro Observations.Concurrent dual contrast for cellular magnetic resonance imaging using gadolinium oxide and iron oxide nanoparticles In vitro labeling of endothelial progenitor cells isolated from peripheral blood with superparamagnetic iron oxide nanoparticles.Human serum albumin coated iron oxide nanoparticles for efficient cell labeling.Magnetic resonance imaging of ferumoxide-labeled mesenchymal stem cells in cartilage defects: in vitro and in vivo investigations.Cellular MRI and its role in stem cell therapy.Detection and quantification of magnetically labeled cells by cellular MRI Ferumoxytol: a new, clinically applicable label for stem-cell tracking in arthritic joints with MRI.Investigation of relationships between transverse relaxation rate, diffusion coefficient, and labeled cell concentration in ischemic rat brain using MRI.Rat model of metastatic breast cancer monitored by MRI at 3 tesla and bioluminescence imaging with histological correlation Magnetic resonance imaging of chondrocytes labeled with superparamagnetic iron oxide nanoparticles in tissue-engineered cartilage.Tracking the migration of cardially delivered therapeutic stem cells in vivo: state of the art.Magnetic labeling, imaging and manipulation of endothelial progenitor cells using iron oxide nanoparticles.In vivo stem cell tracking in neurodegenerative therapies.Iron oxide-based nanomagnets in nanomedicine: fabrication and applications.Non-invasive in-vivo imaging of stem cells after transplantation in cardiovascular tissue MR detection of LPS-induced neutrophil activation using mannan-coated superparamagnetic iron oxide nanoparticles.Gd₂O₃ nanoparticles in hematopoietic cells for MRI contrast enhancement.Depicting adoptive immunotherapy for prostate cancer in an animal model with magnetic resonance imaging.A novel magnetic approach to enhance the efficacy of cell-based gene therapies.

P2860

Q21129471-AC8F1D1F-2055-49B1-9DBC-1579F1C23906 Q24599399-54D14FDF-B7F1-4426-8103-133B193CFFE4 Q28476235-EAADD6C7-30BA-4D58-A556-2C4962537310 Q28817539-AF6CC656-BBFA-4956-A3FB-A25F2F4E67A3 Q30497931-90C3FF5E-D92B-4F7B-82C5-A4747179143D Q30930526-ADE234D8-810D-4B6E-938D-91508DFEC884 Q31032909-D5A9CD51-72D6-4D43-A654-7F2C302C5CA3 Q33503551-A4678953-26AA-4455-9951-0B5B1B37A80E Q33663145-C9B2AD3F-83D6-4E7D-B8E0-EC4E1041537B Q33690064-6B4C0F96-4FF3-40C8-8C08-9FDF43163DEF Q33760563-3356B4E6-45EE-4A71-8BFC-CBE12DAC8BEA Q33824227-DB72B028-8BE1-4753-A545-984AEF0770F1 Q33949771-E9817ED4-C14C-4B45-8C90-9C26388EF7DE Q34022435-8B4AB391-1CB5-4192-B434-FF29D06E8505 Q34105714-EA588BA5-5E88-4BDD-8B4A-4D1E32272E6A Q34673375-1E8F839B-1510-4AB5-A392-07340ABD1402 Q34698260-3FD1D1E7-E3A4-49A7-9EC7-ABF5BABCE261 Q35153280-20DEA014-E57B-4735-BD98-75194DDB65DE Q35681494-0F85A5E4-ECA1-4FC8-B1FD-0DB8F3A4CAC6 Q35968130-41E10253-2670-490B-ABFC-E39219032336 Q35974687-FED68929-E590-46C6-9F92-8A1D663E4703 Q36165164-AAB4AFEE-7E2B-40EF-8E86-F4FC26E92B65 Q36383163-8B77C523-DFB2-4DCF-9287-36A9E95215E6 Q36743711-BE38E4DE-2582-4C83-8E0F-DB804233130C Q37055293-F8E73D92-35BD-49CD-9EC7-A82292FFDB21 Q37096959-C1163C20-9327-4F08-9794-12D85E85A3F2 Q37189031-37461B83-C9D1-4272-896E-EAE438E283F3 Q37275497-EF81DEC3-A62E-40A8-AC2C-9F904B90E72D Q37349450-BD9FC0BB-1CA0-4BE3-876D-EB313447765A Q37414232-19424F31-4FA7-47EC-84D1-BA70489674E6 Q37471467-1EF11F2B-C95B-4289-8EAF-619AE6CBCB36 Q37479807-71BEE426-72C4-4DD5-84EE-C044441A54A5 Q37855910-B7023B5C-888F-4075-8097-709CD4B18AD6 Q37864322-CE620152-8B2E-4034-96EC-FD484C6060D1 Q37959999-58816B6C-CE79-477A-95CE-B16B41769D7E Q38129057-5B53D94A-775E-4D95-AAEA-FAFA3DBD9D97 Q38450486-F1176526-AF99-40A4-9188-A52D745483F0 Q39415273-63027317-C189-4B2B-865D-7B499238FFB3 Q39647341-ABB5E51C-7EC0-4306-B12A-669F50A494D5 Q39991136-354AD9F0-A994-4483-8896-7021E8D3ED05

P2860

Targeting of hematopoietic progenitor cells with MR contrast agents.

http://www.wikidata.org/entity/Q44526114

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年学术文章

@wuu

2003年学术文章

@zh

2003年学术文章

@zh-cn

2003年学术文章

@zh-hans

2003年学术文章

@zh-my

2003年学术文章

@zh-sg

2003年學術文章

@yue

2003年學術文章

@zh-hant

name

Targeting of hematopoietic progenitor cells with MR contrast agents.

@en

Targeting of hematopoietic progenitor cells with MR contrast agents.

@nl

type

label

Targeting of hematopoietic progenitor cells with MR contrast agents.

@en

Targeting of hematopoietic progenitor cells with MR contrast agents.

@nl

prefLabel

Targeting of hematopoietic progenitor cells with MR contrast agents.

@en

Targeting of hematopoietic progenitor cells with MR contrast agents.

@nl

P1433

Q44526114-5F1DE70F-B911-4DF2-8939-FEB1B39FDD00

P1476

Q44526114-9C063BF7-2501-479A-B1E8-B22C178D8A40

P2093

Q44526114-373F8C4D-77A3-49C6-B540-4B7243277322

Q44526114-4D2205AC-2F4A-4C00-963C-94571967517E

Q44526114-6F17F768-2DC0-4FD0-B6E1-4B15FB5A2DAA

Q44526114-81596A8C-10CD-40CE-9DBD-D5DAB80F05DB

Q44526114-81E4B1E4-3F90-40C9-A53F-CBBC917FFB16

Q44526114-94541487-6D54-42A3-8D9F-4A3F781DC9E6

Q44526114-C3324BE5-110E-4B74-B3A4-5A2452801F97

Q44526114-D0F55837-DF84-40B6-8654-4E1920BAFB8F

Q44526114-E84E31B2-F2A1-4B5D-8854-337C473C3994

Q44526114-F6992F47-57D9-48A2-AA7D-2F02DA1A7933

P304

Q44526114-851567C1-D2E5-4D5C-8BDC-6BE7266A9A0E

P31

Q44526114-36EE7241-A71D-4500-9F7D-C86D0A28FC03

P356

Q44526114-D53373D4-2737-4097-AC98-65CB8419B926

P407

Q44526114-AA8C28CD-46AB-4960-978D-3C2B73866DD6

P433

Q44526114-03B09534-7EB4-49F0-B6A5-BBDA728C3576

P478

Q44526114-40BB34FB-E62C-4A0C-98C7-00C48A478725

P50

Q44526114-B31310AF-B729-482D-8079-F4AC844DA525

Q44526114-D9B3B9B8-30B0-45E5-980C-6D968944B0D9

P577

Q44526114-6888E76E-C829-48AF-8732-472B8AA7D361

P5875

Q44526114-5D24D522-916E-42CC-8ABD-2B1D01DB2337

P698

Q44526114-D042FB87-9169-49F4-81C1-E15C23D252ED

P356

RADIOL.2283020322

P1433

P1476

Targeting of hematopoietic progenitor cells with MR contrast agents

@en

P2093

Ernst J Rummeny

http://www.w3.org/2001/XMLSchema#string

Guido Piontek

http://www.w3.org/2001/XMLSchema#string

Hilkea Rosenbrock

http://www.w3.org/2001/XMLSchema#string

Jürgen Schlegel

http://www.w3.org/2001/XMLSchema#string

Marcus Settles

http://www.w3.org/2001/XMLSchema#string

Martina Rudelius

http://www.w3.org/2001/XMLSchema#string

Stefan Metz

http://www.w3.org/2001/XMLSchema#string

Thomas M Link

http://www.w3.org/2001/XMLSchema#string

Ulrich Heinzmann

http://www.w3.org/2001/XMLSchema#string

Ulrich Keller

http://www.w3.org/2001/XMLSchema#string

P304

760-767

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1148/RADIOL.2283020322

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

228

http://www.w3.org/2001/XMLSchema#string

P50

Heike E Daldrup-Link

Robert Oostendorp

P577

2003-07-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

10643335

http://www.w3.org/2001/XMLSchema#string

P698

12881578

http://www.w3.org/2001/XMLSchema#string